0001140361-16-077473.txt : 20160822 0001140361-16-077473.hdr.sgml : 20160822 20160822185259 ACCESSION NUMBER: 0001140361-16-077473 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160818 FILED AS OF DATE: 20160822 DATE AS OF CHANGE: 20160822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greiner Michael CENTRAL INDEX KEY: 0001520392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 161846200 MAIL ADDRESS: STREET 1: C/O VISTAPRINT STREET 2: 95 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc1.xml FORM 4 X0306 4 2016-08-18 0 0001275187 ANGIODYNAMICS INC ANGO 0001520392 Greiner Michael 14 PLAZA DRIVE LATHAM NY 12110 0 1 0 0 EVP and CFO Common Stock 2016-08-18 4 A 0 10000 0 A 10000 D Non-Qualified Stock Option (right to buy) 16.07 2016-08-18 4 A 0 100000 0 A 2017-08-18 2023-08-18 Common Stock 100000 100000 D Performance Right 2016-08-18 4 A 0 20000 0 A Common Stock 20000 20000 D This acquisition of 10,000 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 10,000 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on August 18, 2017, such that 25% of the restricted stock units will vest on each of August 18, 2017, 2018, 2019 and 2020. These stock options vest in four equal annual installments beginning on August 18, 2017, such that 25% of the options will vest on each of August 18, 2017, 2018, 2019 and 2020. Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2017, 2018 and 2019. Any shares that do not vest at the end of the performance period will be forfeited. /s/ Stephen A. Trowbridge, Attorney in Fact 2016-08-22